Dave Chase is on a mission to restore hope, health, and economic wellbeing to communities through healthcare transformation. As creator of the community-owned health plan (COHP) model, he is building a nationwide movement that turns health plans from drivers of wage stagnation into vessels for wellbeing and wealth creation. As founder of Health Rosetta, Dave has helped transform healthcare for thousands of employers covering 5+ million Americans. What began with identifying just 5 successful health plans nationwide has grown into a movement with thousands of sustainable successes that deliver superior care at 20-50% lower costs. In 2024, his team launched Nautilus Health Institute, catalyzed with $4M in Health Rosetta intellectual property and investment. Nautilus provides open-source standards, contracting templates, and technology infrastructure. https://www.linkedin.com/in/chasedave/

Deborah Williams is a nationally recognized health policy expert with a proven track record driving legislative and regulatory change across the U.S. healthcare ecosystem. With experience on the U.S. House Ways & Means Committee and senior advisory roles at organizations like American Hospital Association and Evernorth/Express Scripts, she has helped shape major reforms in drug pricing transparency and pharmacy benefit management.

Mark Galvin: a thought leader and staunch advocate for price transparency and consumerism in healthcare for more than 17 years. He co-founded TALON in 2014 to create and supply a platform supporting a more competitive, efficient healthcare marketplace. In 2018, Mark was invited to speak with and present TALON to the White House Health Policy Team tasked with developing the Transparency in Coverage Rule, including officials from the Departments of Health & Human Services, Treasury, Labor, the Centers for Medicare and Medicaid Services, and the Office of Personnel Management. TALON was subsequently used as the model upon which the new Transparency in Coverage and No Surprises Act federal mandates are based. A serial entrepreneur, Mark has launched a dozen companies and two technology accelerators. Four of his venture-backed tech firms achieved growth levels ranking each in the 100 fastest-growing private companies in the United States as measured by the Inc. 500. 

Stan Mehr is a veteran clinical and health policy writer with 35+ years of experience in pharma, managed care, and healthcare publishing. He specializes in translating complex topics like drug pricing, reimbursement, and market access into actionable insights. As founder and editor of Biosimilars Review & Report (www.biosimilarsrr.com), Stan is a leading voice on biosimilars, FDA approvals, and healthcare reform. His work bridges editorial expertise with strategic consulting—helping stakeholders navigate policy shifts and optimize access to affordable therapies.

Steve is the author of The Health Plan Compliance Advantage Fiduciary Handbook, Newsletter, and Education Courses for executives, board directors, and employer health plan fiduciaries.  

As a senior healthcare executive and consultant, Steve has helped healthcare organizations develop innovative solutions to improve healthcare value, quality, and cost. Steve is a Fellow at the new First College of Medicine, where he advises the Department of Health Systems Science on training the next generation of physicians and pharmacists in the business of healthcare. He leads a project examining the PBM industry and employer pharmacy benefits to improve compliance, cost effectiveness, and clinical outcomes. Steve was recently appointed as a Board Adviser with Nautilus, the not-for-profit arm of Health Rosetta, where he is leading their open-source PBM Field Guide project. linkedin.com/in/stevenditto/